BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38334470)

  • 1. Breast Cancer Detection Using a Low-Dose Positron Emission Digital Mammography System.
    Freitas V; Li X; Scaranelo A; Au F; Kulkarni S; Ghai S; Taeb S; Bubon O; Baldassi B; Komarov B; Parker S; Macsemchuk CA; Waterston M; Olsen KO; Reznik A
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230020. PubMed ID: 38334470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
    AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
    Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Ozonoff A; Miller JP; Kalinyak JE
    Radiology; 2011 Jan; 258(1):59-72. PubMed ID: 21076089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging.
    Schilling K; Narayanan D; Kalinyak JE; The J; Velasquez MV; Kahn S; Saady M; Mahal R; Chrystal L
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):23-36. PubMed ID: 20871992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
    Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
    Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
    Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
    Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Watanabe G; Itoh M; Duan X; Watabe H; Mori N; Tada H; Suzuki A; Miyashita M; Ohuchi N; Ishida T
    Eur Radiol; 2018 May; 28(5):1929-1937. PubMed ID: 29218614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
    Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
    J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary report of breast cancer screening by positron emission mammography.
    Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
    Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
    Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
    Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
    Kalinyak JE; Berg WA; Schilling K; Madsen KS; Narayanan D; Tartar M
    Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):260-75. PubMed ID: 24085500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron Emission Mammography Image Interpretation for Reduced Image Count Levels.
    MacDonald LR; Hippe DS; Bender LC; Cotter EW; Voria PR; Hallam PS; Wang CL; Haseley DR; Kelly MM; Parikh JR; Beatty JD; Rogers JV
    J Nucl Med; 2016 Mar; 57(3):348-54. PubMed ID: 26635337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?
    Bitencourt AG; Lima EN; Macedo BR; Conrado JL; Marques EF; Chojniak R
    Eur Radiol; 2017 May; 27(5):1893-1900. PubMed ID: 27585658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
    Tafra L; Cheng Z; Uddo J; Lobrano MB; Stein W; Berg WA; Levine E; Weinberg IN; Narayanan D; Ross E; Beylin D; Yarnall S; Keen R; Sawyer K; Van Geffen J; Freimanis RL; Staab E; Adler LP; Lovelace J; Shen P; Stewart J; Dolinsky S
    Am J Surg; 2005 Oct; 190(4):628-32. PubMed ID: 16164937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis.
    Caldarella C; Treglia G; Giordano A
    Clin Breast Cancer; 2014 Aug; 14(4):241-8. PubMed ID: 24472718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission mammography: diagnostic imaging and biopsy on the same day.
    Argus A; Mahoney MC
    AJR Am J Roentgenol; 2014 Jan; 202(1):216-22. PubMed ID: 24370147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
    Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
    AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
    Noritake M; Narui K; Kaneta T; Sugae S; Sakamaki K; Inoue T; Ishikawa T
    Clin Nucl Med; 2017 Mar; 42(3):169-175. PubMed ID: 28072617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility.
    Narayanan D; Madsen KS; Kalinyak JE; Berg WA
    AJR Am J Roentgenol; 2011 Apr; 196(4):971-81. PubMed ID: 21427351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of positron emission mammography: feature analysis and rates of malignancy.
    Narayanan D; Madsen KS; Kalinyak JE; Berg WA
    AJR Am J Roentgenol; 2011 Apr; 196(4):956-70. PubMed ID: 21427350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.